BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2140916)

  • 1. Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
    Fahr A; Hiestand P; Ryffel B
    Transplant Proc; 1990 Jun; 22(3):1116-24. PubMed ID: 2140916
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.
    Granelli-Piperno A; Keane M
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):136-42. PubMed ID: 2966477
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
    Freed BM; Rosano TG; Quick C; Lempert N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.
    Bunjes D; Hardt C; Röllinghoff M; Wagner H
    Eur J Immunol; 1981 Aug; 11(8):657-61. PubMed ID: 6456149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
    Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
    J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of the immunosuppressive properties of Sch 24937.
    Smith SR; Terminelli C; Epps S; Watnick A; Umland S
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):333-59. PubMed ID: 2963854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction.
    Bierer BE; Schreiber SL; Burakoff SJ
    Transplantation; 1990 Jun; 49(6):1168-70. PubMed ID: 1694317
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the biological activity of cyclosporine metabolites using the human JURKAT cell line.
    Freed BM; Stevens C; Brooks C; Cramer S; Lempert N; Rosano TG
    Transplant Proc; 1991 Feb; 23(1 Pt 2):980-1. PubMed ID: 1989352
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of action of cyclosporin A].
    Wagner H; Hardt C; Heeg K
    Internist (Berl); 1985 Sep; 26(9):530-3. PubMed ID: 2933358
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune-suppressive activity of punicalagin via inhibition of NFAT activation.
    Lee SI; Kim BS; Kim KS; Lee S; Shin KS; Lim JS
    Biochem Biophys Res Commun; 2008 Jul; 371(4):799-803. PubMed ID: 18466764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil selectively inhibits expression of interleukin-2 messenger RNA in mitogen activated mononuclear blood cells.
    Zanker B; Walz G; Wieder KJ; Moscovitch-Lopatin M; Smith BR; Strom TB
    Transplant Proc; 1989 Feb; 21(1 Pt 1):85-7. PubMed ID: 2784906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.